Cargando…

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

PURPOSE: The Tamoxifen and Exemestane Trial (TEXT)/Suppression of Ovarian Function Trial (SOFT) showed superior outcomes for premenopausal women with hormone receptor (HR)–positive breast cancer treated with adjuvant exemestane plus ovarian function suppression (OFS) or tamoxifen plus OFS versus tam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagani, Olivia, Francis, Prudence A., Fleming, Gini F., Walley, Barbara A., Viale, Giuseppe, Colleoni, Marco, Láng, István, Gómez, Henry L., Tondini, Carlo, Pinotti, Graziella, Di Leo, Angelo, Coates, Alan S., Goldhirsch, Aron, Gelber, Richard D., Regan, Meredith M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2020
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164485/ https://www.ncbi.nlm.nih.gov/pubmed/31618131 http://dx.doi.org/10.1200/JCO.18.01967

Ejemplares similares

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
por: Conforti, Fabio, et al.
Publicado: (2019)

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
por: Johansson, Harriet, et al.
Publicado: (2016)

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer
por: Torrisi, R, et al.
Publicado: (2007)

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
por: Coates, A. S., et al.
Publicado: (2015)

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
por: Dowsett, Mitch, et al.
Publicado: (2018)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
por: Coates, Alan S, et al.
Publicado: (2012)

An Ultra-Precision Absolute-Type Multi-Degree-of-Freedom Grating Encoder
por: Wang, Shengtong, et al.
Publicado: (2022)

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date
por: Criscitiello, Carmen, et al.
Publicado: (2018)

The 6th Milan Breast Cancer Conference, Milan, Italy, 16–18 June 2004
por: Gennari, Roberto, et al.
Publicado: (2005)

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
por: Ribi, Karin, et al.
Publicado: (2019)

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
por: Ribi, Karin, et al.
Publicado: (2020)

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
por: Goldhirsch, A., et al.
Publicado: (2011)

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
por: Goldhirsch, A., et al.
Publicado: (2009)

Reply to F. Tomao et al
por: Ribi, Karin, et al.
Publicado: (2016)

Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer
por: Ni, Hua, et al.
Publicado: (2021)

Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials()
por: Pala, Laura, et al.
Publicado: (2023)

Cranio-Orbito-Zygomatic Approach: Core Techniques for Tailoring Target Exposure and Surgical Freedom
por: Luzzi, Sabino, et al.
Publicado: (2022)

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
por: Ribi, K, et al.
Publicado: (2012)

International Web-based consultation on priorities for translational breast cancer research
por: Dowsett, Mitch, et al.
Publicado: (2007)

Characterization of Angle Accuracy and Precision of 3-Degree-of-Freedom Absolute Encoder Based on NanoGPS OxyO Technology
por: Pisani, Marco, et al.
Publicado: (2020)

Premenopausal osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2013)

Freedom of the will /
por: Edwards, Jonathan, 1703-1758
Publicado: (1969)

Freedom /
por: Franzen, Jonathan

Freedom
Publicado: (1890)

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial
por: Sun, Zhuoxin, et al.
Publicado: (2020)

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity
por: Torrisi, R, et al.
Publicado: (2008)

Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer
por: Bernhard, J, et al.
Publicado: (2008)

Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations()
por: Conforti, Fabio, et al.
Publicado: (2021)

Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer
por: Orlando, Laura, et al.
Publicado: (2006)

Impact of autoimmune diseases on outcome of patients with early breast cancer
por: Criscitiello, Carmen, et al.
Publicado: (2016)

Factors that predict early treatment failure for patients with locally advanced (T4) breast cancer
por: Montagna, E, et al.
Publicado: (2008)

Freedom and reason
por: Hare, R. M. (Richard Mervyn)
Publicado: (1963)

Freedom and determinism.
por: Lehrer, Keith
Publicado: (1966)

Freedom in the groove
por: Redman, Joshua
Publicado: (1996)

Freedom and reason
por: Hare, R. M. (Richard Mervyn)
Publicado: (1963)

Capitalism and freedom /
por: Friedman, Milton, 1912-2006
Publicado: (1962)

Freedom not aggregation
por: Wells, William A.
Publicado: (2005)

Freedom in condensation
por: LeBrasseur, Nicole
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_gprl1c3qfmamll1h1cdo1ppnrp